Table 1. Prevalence of Alcohol, Cannabis, Opioid, and Stimulant Use Disorders in the US Based on the Benchmark Multiplier Methoda and National Survey on Drug Use and Health (NSDUH) 2018-2019.
| Substance use disorder | % (95% CI) | |||||
|---|---|---|---|---|---|---|
| Combined 2018-2019 | 2018 | 2019 | ||||
| Multiplier method | NSDUH | Multiplier method | NSDUH | Multiplier method | NSDUH | |
| Alcohol use disorder | 20.27 (17.04-24.71) | 5.34 (5.10-5.58) | 18.99 (14.94-25.02) | 5.38 (5.11-5.66) | 21.84 (16.89-29.40) | 5.29 (4.98-5.63) |
| Cannabis use disorderb | 7.57 (5.96-9.98) | 1.68 (1.59-1.79) | 8.10 (5.70-12.29) | 1.62 (1.48-1.76) | 7.17 (5.21-10.40) | 1.75 (1.62-1.90) |
| Opioid use disorderc | 3.46 (2.97-4.12) | 0.68 (0.60-0.78) | 3.13 (2.56-3.96) | 0.75 (0.63-0.89) | 3.84 (3.04-5.04) | 0.62 (0.53-0.72) |
| Stimulants use disorderd | 1.91 (1.63-2.30) | 0.85 (0.75-0.96) | 2.13 (1.67-2.83) | 0.85 (0.74-0.98) | 1.74 (1.41-2.22) | 0.85 (0.72-1.00) |
a
The multiplier for the benchmark multiplier method was computed as the proportion of participants with substance use disorders in NSDUH who used treatments generally covered by insurance and were covered by Medicaid.
b
Includes marijuana and hashish.
c
Includes heroin and prescription opioids.
d
Includes cocaine, methamphetamine, and prescription stimulants.